FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | Sample | Privacy
Related Topics >> FDA regulation | Margaret Hamburg

FDA preps to toughen up

Free Newsletter

FiercePharma Manufacturing provides must-know news and insight on the hardware and software tools used to automate pharmaceutical manufacturing. Sign up today to receive your FREE "insiders only" weekly pharma manufacturing industry briefing.



Tools

Top among commissioner Margaret Hamburg's six steps towards a strong FDA are a 15-day post-inspection deadline for response by out-of-compliance companies, and then a formal close-out process in which the FDA certifies that the corrections have been made, both by letter and on its website (see previous item, "Hamburg pushes toward ‘strong FDA'").

The remaining steps involve actions to further ensure that violations are taken seriously and actions are quick. The regulator will speed up its process of issuing warning letters by limiting their review to "significant legal issues." As a result, most enforcement letters will enjoy a "more streamlined process. This approach is consistent with the FDA's longstanding historical practice," says Hamburg.

The FDA will also prioritize enforcement via such prompt follow-up as an inspection or investigation.

In addition, regulators will be "prepared to act swiftly and aggressively to protect the public." No more multiple warning letters prior to enforcement action. "If we find that we must move quickly to address significant health concerns or egregious violations," says Hamburg, "we will consider immediate action--even before we have issued a formal warning letter."

- see Hamburg's talk in a 25-minute web cast
- here's the text

Related Articles:
Hamburg 'honeymoon' could aid FDA reform
Can a tough, persuasive Hamburg overhaul FDA?
FDA wants to keep fewer secrets
FDA chiefs: We're for public health


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Manufacturing Email Newsletter:

More stories about FDA regulation   Margaret Hamburg